MicroRNA-17-92 Regulates Beta-Cell Restoration After Streptozotocin Treatment

Objective: To clarify the role and mechanism of miR-17-92 cluster in islet beta-cell repair after streptozotocin intervention.Methods: Genetically engineered mice (miR-17-92βKO) and control RIP-Cre mice were intraperitoneally injected with multiple low dose streptozotocin. Body weight, random blood...

Full description

Bibliographic Details
Main Authors: Shan Wan, Jie Zhang, Xiang Chen, Jiangli Lang, Li Li, Fei Chen, Li Tian, Yang Meng, Xijie Yu
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-01-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fendo.2020.00009/full
id doaj-598716468c624f0ca31f003541d03d37
record_format Article
spelling doaj-598716468c624f0ca31f003541d03d372020-11-25T02:14:13ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922020-01-011110.3389/fendo.2020.00009510222MicroRNA-17-92 Regulates Beta-Cell Restoration After Streptozotocin TreatmentShan Wan0Jie Zhang1Xiang Chen2Jiangli Lang3Li Li4Fei Chen5Li Tian6Yang Meng7Yang Meng8Xijie Yu9Laboratory of Endocrinology and Metabolism, Department of Endocrinology, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, ChinaHistology and Imaging Platform, Core Facility of West China Hospital, Sichuan University, Chengdu, ChinaLaboratory of Endocrinology and Metabolism, Department of Endocrinology, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, ChinaLaboratory of Endocrinology and Metabolism, Department of Endocrinology, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, ChinaHistology and Imaging Platform, Core Facility of West China Hospital, Sichuan University, Chengdu, ChinaHistology and Imaging Platform, Core Facility of West China Hospital, Sichuan University, Chengdu, ChinaLaboratory of Endocrinology and Metabolism, Department of Endocrinology, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, ChinaLaboratory of Endocrinology and Metabolism, Department of Endocrinology, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Orthopedics, West China Hospital, Sichuan University, Chengdu, ChinaLaboratory of Endocrinology and Metabolism, Department of Endocrinology, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, ChinaObjective: To clarify the role and mechanism of miR-17-92 cluster in islet beta-cell repair after streptozotocin intervention.Methods: Genetically engineered mice (miR-17-92βKO) and control RIP-Cre mice were intraperitoneally injected with multiple low dose streptozotocin. Body weight, random blood glucose (RBG), fasting blood glucose, and intraperitoneal glucose tolerance test (IPGTT) were monitored regularly. Mice were sacrificed for histological analysis 8 weeks later. Morphological changes of pancreas islets, quantity, quality, apoptosis, and proliferation of beta-cells were measured. Islets from four groups were isolated. MiRNA and mRNA were extracted and quantified.Results:MiR-17-92βKO mice showed dramatically elevated fasting blood glucose and impaired glucose tolerance after streptozotocin treatment in contrast to control mice, the reason of which is reduced beta-cell number and total mass resulting from reduced proliferation, enhanced apoptosis of beta-cells. Genes related to cell proliferation and insulin transcription repression were significantly elevated in miR-17-92βKO mice treated with streptozotocin. Furthermore, genes involved in DNA biosynthesis and damage repair were dramatically increased in miR-17-92βKO mice with streptozotocin treatment.Conclusion: Collectively, our results demonstrate that homozygous deletion of miR-17-92 cluster in mouse pancreatic beta-cells promotes the development of experimental diabetes, indicating that miR-17-92 cluster may be positively related to beta-cells restoration and adaptation after streptozotocin-induced damage.https://www.frontiersin.org/article/10.3389/fendo.2020.00009/fullmiR-17-92 clusterpancreatic beta-cellsstreptozotocinrestorationCdkn1aATM kinase
collection DOAJ
language English
format Article
sources DOAJ
author Shan Wan
Jie Zhang
Xiang Chen
Jiangli Lang
Li Li
Fei Chen
Li Tian
Yang Meng
Yang Meng
Xijie Yu
spellingShingle Shan Wan
Jie Zhang
Xiang Chen
Jiangli Lang
Li Li
Fei Chen
Li Tian
Yang Meng
Yang Meng
Xijie Yu
MicroRNA-17-92 Regulates Beta-Cell Restoration After Streptozotocin Treatment
Frontiers in Endocrinology
miR-17-92 cluster
pancreatic beta-cells
streptozotocin
restoration
Cdkn1a
ATM kinase
author_facet Shan Wan
Jie Zhang
Xiang Chen
Jiangli Lang
Li Li
Fei Chen
Li Tian
Yang Meng
Yang Meng
Xijie Yu
author_sort Shan Wan
title MicroRNA-17-92 Regulates Beta-Cell Restoration After Streptozotocin Treatment
title_short MicroRNA-17-92 Regulates Beta-Cell Restoration After Streptozotocin Treatment
title_full MicroRNA-17-92 Regulates Beta-Cell Restoration After Streptozotocin Treatment
title_fullStr MicroRNA-17-92 Regulates Beta-Cell Restoration After Streptozotocin Treatment
title_full_unstemmed MicroRNA-17-92 Regulates Beta-Cell Restoration After Streptozotocin Treatment
title_sort microrna-17-92 regulates beta-cell restoration after streptozotocin treatment
publisher Frontiers Media S.A.
series Frontiers in Endocrinology
issn 1664-2392
publishDate 2020-01-01
description Objective: To clarify the role and mechanism of miR-17-92 cluster in islet beta-cell repair after streptozotocin intervention.Methods: Genetically engineered mice (miR-17-92βKO) and control RIP-Cre mice were intraperitoneally injected with multiple low dose streptozotocin. Body weight, random blood glucose (RBG), fasting blood glucose, and intraperitoneal glucose tolerance test (IPGTT) were monitored regularly. Mice were sacrificed for histological analysis 8 weeks later. Morphological changes of pancreas islets, quantity, quality, apoptosis, and proliferation of beta-cells were measured. Islets from four groups were isolated. MiRNA and mRNA were extracted and quantified.Results:MiR-17-92βKO mice showed dramatically elevated fasting blood glucose and impaired glucose tolerance after streptozotocin treatment in contrast to control mice, the reason of which is reduced beta-cell number and total mass resulting from reduced proliferation, enhanced apoptosis of beta-cells. Genes related to cell proliferation and insulin transcription repression were significantly elevated in miR-17-92βKO mice treated with streptozotocin. Furthermore, genes involved in DNA biosynthesis and damage repair were dramatically increased in miR-17-92βKO mice with streptozotocin treatment.Conclusion: Collectively, our results demonstrate that homozygous deletion of miR-17-92 cluster in mouse pancreatic beta-cells promotes the development of experimental diabetes, indicating that miR-17-92 cluster may be positively related to beta-cells restoration and adaptation after streptozotocin-induced damage.
topic miR-17-92 cluster
pancreatic beta-cells
streptozotocin
restoration
Cdkn1a
ATM kinase
url https://www.frontiersin.org/article/10.3389/fendo.2020.00009/full
work_keys_str_mv AT shanwan microrna1792regulatesbetacellrestorationafterstreptozotocintreatment
AT jiezhang microrna1792regulatesbetacellrestorationafterstreptozotocintreatment
AT xiangchen microrna1792regulatesbetacellrestorationafterstreptozotocintreatment
AT jianglilang microrna1792regulatesbetacellrestorationafterstreptozotocintreatment
AT lili microrna1792regulatesbetacellrestorationafterstreptozotocintreatment
AT feichen microrna1792regulatesbetacellrestorationafterstreptozotocintreatment
AT litian microrna1792regulatesbetacellrestorationafterstreptozotocintreatment
AT yangmeng microrna1792regulatesbetacellrestorationafterstreptozotocintreatment
AT yangmeng microrna1792regulatesbetacellrestorationafterstreptozotocintreatment
AT xijieyu microrna1792regulatesbetacellrestorationafterstreptozotocintreatment
_version_ 1724901098159865856